Balchem Corporation EBITDA Margin for the Trailing 12 Months (TTM) ending March 31, 2025: 23.45%

Balchem Corporation EBITDA Margin is 23.45% for the Trailing 12 Months (TTM) ending March 31, 2025, a -1.96% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.
  • Balchem Corporation EBITDA Margin for the Trailing 12 Months (TTM) ending March 31, 2024 was 23.92%, a 15.23% change year over year.
  • Balchem Corporation EBITDA Margin for the Trailing 12 Months (TTM) ending March 31, 2023 was 20.75%, a 2.05% change year over year.
  • Balchem Corporation EBITDA Margin for the Trailing 12 Months (TTM) ending March 31, 2022 was 20.34%, a -13.15% change year over year.
  • Balchem Corporation EBITDA Margin for the Trailing 12 Months (TTM) ending March 31, 2021 was 23.42%, a 3.38% change year over year.
Key Data
Date EBITDA Margin Net Income Margin EBT Margin Operating Income Margin